Measurement of RBD binding antibodies, RBM binding antibodies, and non-RBM binding antibodies in vaccinee plasma by BLI

CL Cheng Li
WZ Wuqiang Zhan
ZY Zhenlin Yang
CT Chao Tu
GH Gaowei Hu
XZ Xiang Zhang
WS Wenping Song
SD Shujuan Du
YZ Yuanfei Zhu
KH Keke Huang
YK Yu Kong
MZ Meng Zhang
QM Qiyu Mao
XG Xiaodan Gu
YZ Yi Zhang
YX Youhua Xie
QD Qiang Deng
YS Yuanlin Song
ZC Zhenguo Chen
LL Lu Lu
SJ Shibo Jiang
YW Yanling Wu
LS Lei Sun
TY Tianlei Ying
request Request a Protocol
ask Ask a question
Favorite

The SA biosensors immobilized with biotin-labeled RBD were incubated with plasma and the signal represented RBD binding antibodies. To further determine the RBM binding antibodies and non-RBM binding antibodies, the competition assay was performed. The SA biosensors loaded with RBD were immersed into 200 nM ACE2 (Novoprotein) until the binding curve reaching saturation, confirming that the RBM of RBD was occupied by ACE2. After that, the complex was incubated 1:50 diluted plasma mixed with 200 nM ACE2. The binding signal indicated that antibodies bind to other regions on RBD except RBM region. The RBM antibodies were determined by RBD antibodies minus non-RBM antibodies. Spearman’s rank correlation test was applied to measure the correlation between plasma neutralization ID50 against Omicron with the RBM antibodies or non-RBM antibodies.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A